Scarica l'app Stockscreener
341.85
5.86%
18.93
Dopo l'orario di chiusura:
341.85
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ELV Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$322.92
Aprire:
$315.46
Volume 24 ore:
4.36M
Relative Volume:
2.76
Capitalizzazione di mercato:
$75.97B
Reddito:
$194.82B
Utile/perdita netta:
$5.53B
Rapporto P/E:
13.98
EPS:
24.4514
Flusso di cassa netto:
$3.77B
1 W Prestazione:
-7.58%
1M Prestazione:
-2.30%
6M Prestazione:
+19.54%
1 anno Prestazione:
-15.68%
Intervallo 1D:
$315.46
$347.47
Intervallo di 1 settimana:
$315.46
$378.44
Portata 52W:
$273.71
$458.73
Elevance Health Inc Stock (ELV) Company Profile
Nome
Elevance Health Inc
Settore
Industria
Telefono
(800) 331-1476
Indirizzo
220 VIRGINIA AVENUE, INDIANAPOLIS
Confronta ELV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ELV
Elevance Health Inc
|
341.85 | 71.77B | 194.82B | 5.53B | 3.77B | 24.45 |
|
UNH
Unitedhealth Group Inc
|
294.02 | 256.08B | 447.57B | 12.81B | 16.08B | 13.19 |
|
CVS
Cvs Health Corp
|
74.03 | 91.40B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
CI
Cigna Group
|
272.38 | 72.15B | 268.22B | 6.55B | 7.44B | 22.67 |
|
HUM
Humana Inc
|
194.01 | 25.01B | 126.36B | 1.30B | 1.55B | 10.67 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-08 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-12-19 | Downgrade | Deutsche Bank | Buy → Hold |
| 2025-10-14 | Iniziato | Goldman | Neutral |
| 2025-07-21 | Downgrade | Argus | Buy → Hold |
| 2025-07-18 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2025-04-15 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-03-17 | Aggiornamento | Argus | Hold → Buy |
| 2025-01-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2024-10-18 | Downgrade | Argus | Buy → Hold |
| 2024-07-18 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-06-24 | Iniziato | Morgan Stanley | Overweight |
| 2024-05-30 | Iniziato | Robert W. Baird | Outperform |
| 2024-03-06 | Iniziato | Barclays | Overweight |
| 2023-07-12 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2023-04-27 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-03-28 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-09-09 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-08-22 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
Mostra tutto
Elevance Health Inc Borsa (ELV) Ultime notizie
Elevance Health Earnings Call Flags Reset Before Rebound - TipRanks
Elevance Health Inc (ELV) Q4 2025 Earnings Call Highlights: Stro - GuruFocus
Elevance Health Inc (ELV) Q4 2025 Earnings Call Highlights: Strong Financial Performance Amid ... - Yahoo Finance
Elevance Health sets 'prudent' 2026 guidance as it navigates ongoing cost, utilization pressures - Fierce Healthcare
Elevance Health ELV stock price jumps 6% after earnings, but 2026 outlook points to revenue dip - TechStock²
Elevance Health targets at least $25.50 adjusted EPS for 2026 as company signals margin recovery and portfolio repositioning - MSN
A Weak Near-Term Outlook Does Not Erase Elevance's Long-Term Competitive Advantages - Morningstar
Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2026 - marketscreener.com
Elevance making difficult decisions amid healthcare minefield - InsuranceNewsNet
Elevance Health Q4 Earnings Beat Estimates on Increasing Premiums - TradingView
Elevance Health Q4 2025 Financial Results & 2026 OutlookNews and Statistics - IndexBox
Elevance reports improved profit, revenue jump at Carelon - Modern Healthcare
Elevance Health: sees profit decline in 2026 as medical cost pressures mount - marketscreener.com
Elevance Health Q4 Earnings Review: No Sign Of An End To The Pain (NYSE:ELV) - Seeking Alpha
Earnings call transcript: Elevance Health Q4 2025 sees earnings beat, stock dips - Investing.com
Elevance Health (ELV) Deep-Dive: Navigating the 2026 Regulatory Storm and the Carelon Transformation - FinancialContent
US Health Insurer Elevance Health Issues Soft Outlook, Lower Premium Forecast For 2026 - Benzinga
Elevance Health (ELV) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance
Tranche Update on Elevance Health, Inc.'s Equity Buyback Plan announced on October 26, 2004. - marketscreener.com
Elevance Health (NYSE:ELV) Reports Q4 CY2025 In Line With Expectations But Stock Drops - Finviz
Qorvo, Altimmune, United Microelectronics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
Elevance Health, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Elevance Health (ELV) Q4 Earnings Beat Expectations Despite Reve - GuruFocus
Elevance Health (ELV) Projects Adjusted EPS of Minimum $25.50 by FY26 - GuruFocus
Elevance Health (ELV) Beats Q4 Earnings Estimates - Yahoo! Finance Canada
Elevance Health, Inc. Declares Dividend for First Quarter of 2026, Payable on March 25, 2026 - marketscreener.com
Elevance Health: Q4 Earnings Snapshot - kare11.com
Elevance forecasts 2026 profit below estimates, flags revenue decline - marketscreener.com
Elevance Health stock falls after Q4 results (ELV:NYSE) - Seeking Alpha
Elevance Health Q4 Earnings Rise; Guides FY26; Shares Slide Pre-Market - Nasdaq
ELEVANCE HEALTH ($ELV) Releases Q4 2025 Earnings - Quiver Quantitative
Elevance Health Reports Fourth Quarter and Full Year 2025 Results - TradingView
Elevance Health Inc. Profit Climbs In Q4 - Nasdaq
Elevance Health flags earnings decline amid bleak Medicare Advantage proposal - Investing.com
Elevance Health stock gets hit by Medicare rate surprise — what traders watch before earnings - TechStock²
Elevance Health stock sinks 14% as Medicare Advantage rate shock hits insurers ahead of earnings - TechStock²
Healthcare: Managed Care Stocks Plunge Following Almost-Flat Medicare Rate Proposal - Morningstar
Why Elevance Health (ELV) Stock Is Falling Today - Finviz
UnitedHealth leads $80 billion insurer rout on bleak Medicare Advantage proposal - Reuters
US proposes slight rise in 2027 Medicare insurer payments, shares fall - Reuters
A Glimpse of Elevance Health's Earnings Potential - Benzinga
Elevance Health, Inc. $ELV Shares Sold by Maj Invest Holding A S - MarketBeat
Vanguard Personalized Indexing Management LLC Has $9.58 Million Position in Elevance Health, Inc. $ELV - MarketBeat
Humana Stock Down as Medicare Rate Proposal Hits Insurers - Investing.com
Elevance Health, Inc. $ELV Shares Acquired by Evergreen Wealth Management LLC - MarketBeat
CIBC Asset Management Inc Has $11.01 Million Stake in Elevance Health, Inc. $ELV - MarketBeat
Barlow Wealth Partners Inc. Trims Stock Position in Elevance Health, Inc. $ELV - MarketBeat
What To Expect From Elevance Health's (ELV) Q4 Earnings - Finviz
What To Expect From Elevance Health’s (ELV) Q4 Earnings - The Globe and Mail
Anthem Seeks Dismissal Of 'Ghost Network' Class Action - Law360
Analysis Recap: Is Elevance Health Inc backed by strong institutional buying2025 Market Outlook & Low Volatility Stock Recommendations - baoquankhu1.vn
Elevance Health Inc Azioni (ELV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.85%
6.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):